Authors:
Serenius, F
Winbo, I
Dahlquist, G
Kallen, B
Citation: F. Serenius et al., Cause-specific stillbirth and neonatal death in Sweden: a catchment area-based analysis, ACT PAEDIAT, 90(9), 2001, pp. 1054-1061
Authors:
Serenius, F
Winbo, I
Dahlquist, G
Kallen, B
Citation: F. Serenius et al., Regional differences in stillbirth and neonatal death rate in Sweden with a cause-of-death specific analysis, ACT PAEDIAT, 90(9), 2001, pp. 1062-1067
Citation: A. Aberg et al., Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes, EAR HUM DEV, 61(2), 2001, pp. 85-95
Authors:
Kallen, K
Mastroiacovo, P
Castilla, EE
Robert, E
Kallen, B
Citation: K. Kallen et al., VATER non-random association of congenital malformations: Study based on data from four malformation registers, AM J MED G, 101(1), 2001, pp. 26-32
Citation: B. Kallen et Pe. Lygner, Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan, HEADACHE, 41(4), 2001, pp. 351-356
Citation: M. Blomberg et al., Congenital malformations in the southeast of Sweden - a registry study with validation, ACT PAEDIAT, 89(10), 2000, pp. 1238-1243
Citation: B. Kallen et E. Robert, Response to "Case-Control study using only malformed infants who were prenatally exposed to drugs. What do the results mean?" by Prieto L and Martinez-Frias ML, TERATOLOGY, 62(1), 2000, pp. 8-9
Citation: K. Wide et al., Body dimensions of infants exposed to antiepileptic drugs in utero: Observations spanning 25 years, EPILEPSIA, 41(7), 2000, pp. 854-861
Citation: B. Kallen, Hyperemesis gravidarum during pregnancy and delivery outcome: A registry study, NAUSEA AND VOMITING OF PREGNANCY, VOL 1, 2000, pp. 36-40
Authors:
Berkovitch, M
Briggs, GG
Chin, RKH
von Dadelszen, P
Deuchar, N
Gadsby, R
Goodwin, TM
Kallen, B
Koren, G
Lamm, SH
MacKinnon, C
Magee, LA
Neutel, CI
Schofield, A
Scialli, AR
Sullivan, CA
Tierson, FD
Weigel, RM
Citation: M. Berkovitch et al., International consensus on standards for studying the efficacy of pharmacological therapies for nausea and vomiting of pregnancy, NAUSEA AND VOMITING OF PREGNANCY, VOL 1, 2000, pp. 141-145
Citation: B. Kallen, Restriction of the use of drugs with teratogenic properties: Swedish experiences with isotretinoin, TERATOLOGY, 60(2), 1999, pp. 53-53